These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7611607)

  • 21. [Olanzapine-induced diabetes mellitus].
    Kozian R
    Psychiatr Prax; 2002 Sep; 29(6):318-20. PubMed ID: 12224043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a.
    Gori A; Caredda F; Franzetti F; Ridolfo A; Rusconi S; Moroni M
    Lancet; 1995 Jun; 345(8962):1438-9. PubMed ID: 7760627
    [No Abstract]   [Full Text] [Related]  

  • 23. Sudden onset of diabetic ketoacidosis during consensus interferon therapy for chronic viral hepatitis C.
    Nylen ES; Marathe IC; Khan IA; Azevedo R; Hirsch KR
    Am J Med Sci; 2008 Apr; 335(4):329-30. PubMed ID: 18414077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adverse reactions of different treatments in chronic hepatitis C].
    Luca C; Grigore L; Vâţă A; Dorobăţ C
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):991-5. PubMed ID: 20191864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon alfa and development of type 1 diabetes mellitus.
    Koivisto VA
    Lancet; 1992 Nov; 340(8829):1236. PubMed ID: 1359316
    [No Abstract]   [Full Text] [Related]  

  • 26. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
    Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
    Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atezolizumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis and Takotsubo cardiomyopathy.
    Singhal S; Patel G; Singh RB; Goyal A; Avgush K; Koka J
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35793858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
    Kawazoe T; Araki M; Lin Y; Ogawa M; Okamoto T; Yamamura T; Wakakura M; Murata M
    Intern Med; 2012; 51(18):2625-9. PubMed ID: 22989839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
    Tavakoli SA; Arguisola MS
    South Med J; 2003 Jul; 96(7):729-30. PubMed ID: 12940340
    [No Abstract]   [Full Text] [Related]  

  • 30. The development of fulminant type 1 diabetes during chemotherapy for rectal cancer.
    Adachi J; Mimura M; Gotyo N; Watanabe T
    Intern Med; 2015; 54(7):819-22. PubMed ID: 25832949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of chronic hepatitis C developing insulin-dependent diabetes, thyroid autoimmunity and stiff-person syndrome as complications of interferon therapy.
    Scavone G; Zaccardi F; Manto A; Caputo S; Pitocco D; Ghirlanda G
    Diabetes Res Clin Pract; 2010 Aug; 89(2):e36-8. PubMed ID: 20541278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus.
    Yagyu H; Okada K; Sato S; Yamashita Y; Okada N; Osuga J; Nagasaka S; Sugano K; Ishibashi S
    Diabetes Res Clin Pract; 2012 Mar; 95(3):e52-4. PubMed ID: 22154462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autoimmune thyroid disease induced by interferon therapy].
    Murakami M; Kakizaki S; Takayama H; Takagi H; Mori M
    Nihon Rinsho; 1999 Aug; 57(8):1779-83. PubMed ID: 10483250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?
    Tosone G; Borgia G; Gentile I; Cerini R; Conte MC; Orlando R; Piazza M
    Acta Diabetol; 2007 Sep; 44(3):167-9. PubMed ID: 17721757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium-glucose cotransporter 2 inhibitor-associated diabetic ketoacidosis: Report of two cases with hyperglycemic ketoacidosis in type 1 diabetes.
    Harati H; Sharma V; Motazedi A
    J Diabetes; 2016 Jan; 8(1):165. PubMed ID: 26211700
    [No Abstract]   [Full Text] [Related]  

  • 36. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy.
    Conlon KC; Urba WJ; Smith JW; Steis RG; Longo DL; Clark JW
    Cancer; 1990 May; 65(10):2237-42. PubMed ID: 2346907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glucose intolerance induced by interferon therapy].
    Sasaoka T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():760-5. PubMed ID: 12238132
    [No Abstract]   [Full Text] [Related]  

  • 38. Type 1 diabetes mellitus provoked by peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.
    Tanaka J; Sugimoto K; Shiraki K; Beppu T; Yoneda K; Fuke H; Yamamoto N; Ito K; Takei Y
    Intern Med; 2008; 47(8):747-9. PubMed ID: 18421192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.
    Piccolo G; Franciotta D; Versino M; Alfonsi E; Lombardi M; Poma G
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):348. PubMed ID: 8609520
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interferon treatment in chronic HCV hepatitis and autoimmune hypothyroidism].
    Calvo Manuel E; Nieto Sánchez A; Espinos Pérez D
    An Med Interna; 2000 Mar; 17(3):164-5. PubMed ID: 10804649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.